Jing Zou, master tutor and attending physician of the First Affiliated Hospital of Jinan University, Secretary of Parkinson's Disease Center of the First Affiliated Hospital of Jinan University, clinical Doctor of Sun Yat-sen University, postdoctoral Fellow of Clinical Medicine of Jinan University, once went to the Mayo Clinic Neuroscience Center in the United States as a Postdoc Research Fellow. Main research direction: Establish a clinical evaluation system for Parkinson's disease based on big data-sample database, conduct early diagnosis of Parkinson's disease by combining molecular imaging technology, gene analysis, marker detection and other means, formulate an optimized treatment plan that meets evidence-based medical evidence and individual needs, as well as preoperative evaluation, postoperative program control and follow-up management for Parkinson's brain pacemaker (DBS) surgery. In the past 5 years, he has published 14 SCI papers (cumulative impact factor: 60.5, total citations 540) as first/co-author and first corresponding author in Environment International, Movement Disorders, Internationally renowned journals such as Cell death& Disease have published 7 SCI papers (4 in CAS Region 1), with the highest impact factor score of 10.3 for a single paper. At present, he has hosted a number of fund projects, including the National Natural Science Foundation Youth Project, Guangdong Natural Surface, Guangdong Natural Youth, Guangzhou Science and Technology Doctor Qihang and China Postdoctoral Research Fund, and won the clinical talent introduction project of the First Affiliated Hospital of Jinan University. At present, he is the Secretary-General of the MDT Management Committee of Parkinson's and Movement Disorders of Guangdong Health Management Society, the member of the Neurology Branch of Guangdong Research Hospital Society, the member of the Headache branch of Guangdong Stroke Society, the member of the Branch of Integrative Chinese and Western Medicine, Brain and Heart Treatment Professional Physicians of Guangzhou Medical Association, the member of the Chinese Stroke Society, the member of the Chinese Medical Association, the member of the Neurology branch of the Chinese Medical Association. National Natural Science Foundation Project evaluator, International Parkinson's Disease and Movement Disorders Association (MDS), American Academy of Neurology (AAN) Young Scholar Member. Won the Yangcheng Evening News Doctor with Good Hands Award in 2025, the first prize in the Case Contest of Parkinson's and Movement Disorders Rehabilitation Branch of Guangdong Medical Association for Rehabilitation in 2024, and the Travel Award Award of the International Parkinson's Disease and Movement Disorders Conference (MDS) for two consecutive years in 2024 and 2023. Won the first prize in the Outstanding paper Competition for Young Doctors of the 12th Neurology Academic Conference of Guangdong Province (and the 12th Guangdong-Hong Kong-Macao Neurology Academic Conference).

2012.09-2017.06 Sun Yat-sen University, Doctor of Medicine (Ph.D, M.D)

2021.10-now, Attending physician, Department of Neurology, the First Affiliated Hospital of Jinan University

2019.01-2021.10 Postdoctoral Fellow, Department of Neurology, the First Affiliated Hospital of Jinan University

2017.09-2018.12 Research Fellow, Neuroscience Research Center, Mayo Clinic, USA

The clinical evaluation system of Parkinson's disease was established based on the big data-sample database, and the early diagnosis of Parkinson's disease was carried out by combining molecular imaging technology, gene analysis, marker detection and other means, and the optimal treatment plan was formulated in accordance with evidence-based medical evidence and individual needs, as well as the preoperative evaluation, postoperative program control and follow-up management of Parkinson's disease DBS.

[1]Deng Z#, Li L#, Jing Z#, Luo X, Yu F, Zeng W, Bi W*, andZou J* （First corresponding author), Association between environmental phthalates exposure and gut microbiota and metabolome in dementia with Lewy bodies. Environment International. 2024 Aug:190:108806. doi: 10.1016/j.envint.2024.108806. Epub 2024 Jun 8. (中科院一区TOP，IF: 10.3）

[2] Guo, Y.,J. Zou(Co-first author),X. Xu, et al., Short-chain fatty acids combined with intronic DNA methylation of HIF3A: Potential predictors for diabetic cardiomyopathy. Clinical Nutrition. 2021; 40: 3708-3717. (中科院1区TOP，2021 IF: 6.6)

[3] Jing Zou#, Yue Guo#, Lei Wei, Fang Yu, Bo Yu, Anding Xu*, Long Noncoding RNA POU3F3 and a-Synuclein in Plasma L1CAM Exosomes Combined with b-Glucocerebrosidase Activity: Potential Predictors for Parkinson’s Disease. Neurotherapeutics.2020 Mar 31.doi:10.1007/s13311-020-00842-5 (中科院药学1区IF: 5.6)

[4]Jing Zou#, Zhaoyu Chen#, Xiaobo Wei#, Zhigang Chen#, Yongmei Fu, Xiaoyan Yang, Dan Chen, Rui Wang, Peter Jenner, Jia-Hong Lu, Min Li, Zhuohua Zhang, Beisha Tang, Kunlin Jin*, Qing Wang*. Cystatin C as a Potential Therapeutic Mediator against Parkinson's Disease via VEGF-induced Angiogenesis and Enhanced Neuronal Autophagy in Neurovascular Units. Cell Death & Disease. 2017; 7, e; doi:10.1038/cddis.2017.240  (中科院1区TOP，IF: 8.1)

[5] Jing Zou#, Zhigang Chen#, Caiqian Liang#, Yongmei Fu, Xiaobo Wei, Jianjun Lu, Mengqiu Pan, Yue Guo, Xinxue Liao, Huifang Xie, Duobin Wu, Min Li, Lihui Liang*, Penghua Wang*, Qing Wang*. Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson's Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage. Aging & Disease. 2018 Feb 1;9(1):51-65 （IF: 7.0）

[6]Jing Zou#, Rui-Hui Weng#, Zhao-Yu Chen, Xiao-Bo Wei, Rui Wang, Dan Chen, Ying Xia*, Qing Wang*. Position Emission Tomography/Single Photon Emission Tomography Neuroimaging for Detection of Pre-Motor Parkinson’s disease. CNS Neuroscience & Therapeutics. 2016 Mar;22(3):167-77 （IF: 4.8）

[7] Chen D#, Wei X#, Zou J# (Co-first author), Wang R, Liu X, Xu X, Lu J, Wang Z, Tang B, Wang B, Jin K, Wang Q*. Contra-Directional Expression of Serum Homocysteine and Uric Acid as Important Biomarkers of Multiple System Atrophy Severity: A Cross-Sectional Study. Front Cell Neurosci. 2015 Jul 6;9:247 （IF: 4.2）

[8] Xiaobo Wei#, Huimin Gao#,Jing Zou# (Co-first author), Xu Liu, Dan Chen, Jinchi Liao, Yunqi Xu, Long Ma, Beisha Tang, Zhuohua Zhang, Xiang Cai, Kunling Jin, Ying Xia*, Qing Wang*. Contra-directional coupling of Nur77 and Nurr1 in Neurodegeneration: A novel mechanism for Memantine-induced anti-inflammation and anti-mitochondrial impairment. Molecular Neurobiology. 2016 Nov;53(9):5876-5892 （IF: 4.6）

[9]J. Zou, Z. Deng, ZZ. Lu, L. Wei, LL. Wu, F. Yu. The N6-Methyladenosine mRNA Methylase METTL14 Regulates TLR4-mediated intestinal dysfunction in Parkinson’s Disease. Movement Disorders. 2023; 38 (suppl 1). Accessed October 29, 2023. (IF: 7.4)

[10] Lei Wei#, Chuan Chen#, LiDing#, MingshuMo#, Jing Zou, Zhenze Lu, Haiyan Li, Haotian Wu, Yongqiang Dai, Pingyi Xu*, Zhengqi Lu*. Wnt1 Promotes EAAT2 Expression and Mediates the Protective Effects of Astrocytes on Dopaminergic Cells in Parkinson's Disease. Neural Plasticity.2019 Sep 9;2019:1247276 （IF: 3.0）

[11] Peng Zhou#, Ruihui Weng#, Zhaoyu Chen#, Rui Wang, Jing Zou, Xu Liu, Jinchi Liao, Yanping Wang, Ying Xia*, Qing Wang*. TLR4 signaling in MPP+-induced activation of BV-2 cells. Neural Plasticity. 2016;2016:5076740 （IF: 3.0）

[12] Yue Guo#, Xiaodong Zhuang#, Zena Huang#,Jing Zou, Daya Yang, Xun Hu, Zhimin Du, Lichun Wang*, Xinxue Liao* (2017) Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-kB-mediated inflammation both in vitro and in vivo. BBA-molecular basis of disease. 2018 Jan;1864(1):238-251 （IF: 4.2） 

[13]Wang R#, Chen Z#, Fu Y#, Wei X#, Liao J, Liu X, He B, Xu Y, Zou J, Yang X, Weng R, Tan S, McElroy C, Jin K*, Wang Q*. Plasma Cystatin C and High-Density Lipoprotein Are Important Biomarkers of Alzheimer's Disease and Vascular Dementia: A Cross-Sectional Study. Front Aging Neurosci. 2017; 9: 26 （IF: 4.1）

[14] Mengqiu Pan#, Huimin Gao#, Ling Long#, Yunqi Xu, Mei Liu, Jing Zou, Aimin Wu, Xiaobo Wei, Xiaohong Chen, Beisha Tang, Qing Wang*. Serum Uric Acid in Patients with Parkinson’s Disease and Vascular Parkinsonism: a cross-sectional study. Neuroimmunomodulation. 2013;20(1):19-28 （IF:2.2）

1. Project of Natural Science Foundation of Guangdong Province, 2025.01.01-2027.12.31, Host

2.2025 Annual Basic and Applied Basic Research Project (Young Doctor Sailing direction), 2025.01.01-2026.12.31, presided over

3. Provincial Medical Research Foundation of 2024, 2024.07.01-2026.06.30, Host

4. National Natural Science Foundation of China Youth Project, 2021.01.01-2023.12.30, Host

5. Project of Natural Science Foundation of Guangdong Province, 2021.01.01-2024.12.30, Host

6. Youth Fund Project of Regional Joint Fund, Basic and Applied Basic Research Foundation of Guangdong Province, 2020.01.01-2023.12.30, Hosted

7. Postdoctoral Fellowship Project, 2019.07.01-2021.06.30, Host

8. Postdoctoral Foundation, The First Affiliated Hospital of Jinan University, 2019.01.01-2022.12.31, Host

9. Postdoctoral Talent Introduction Project Fund, The First Affiliated Hospital of Jinan University, 2021.10.01-2027.10.01, Director

Teaching of Neurology for international and Indian undergraduates

Secretary General of the MDT Management Committee for Parkinson's and Movement Disorders of Guangdong Health Management Society, Member of Neurology Branch of Guangdong Research Hospital Society, member of Headache Branch of Guangdong Stroke Society, member of Guangzhou Medical Association of Integrated Chinese and Western Medicine, Brain and Heart Treatment Professional Physicians Branch, member of Chinese Stroke Society, member of Chinese Medical Association, member of Neurology Branch of Chinese Medical Association, member of Guangdong Medical Association. Project evaluator of National Natural Science Foundation of China, Secretary of Parkinson's Disease Center, First Affiliated Hospital of Jinan University, Member of Parkinson's Disease and Movement Disorders International Association (MDS), Young Scholar of American Academy of Neurology (AAN), Independent reviewers for journals such as Bioscience Reports, Brain Injury and Translational Neuroscience.